Skip to main content Skip to navigation 800-789-7366
headshot of Jami D. Rothman, MD, ScM

Jami D. Rothman, MD, ScM

Breast Surgery
No patient ratings. Why not?
Why doesn't this doctor have a rating?

There is no publicly available rating for this medical professional for one of the following reasons:

  • They are not employed by Penn Medicine.
  • They do not see patients.
  • They see patients but have not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.

Sees patients age 15 and up

  • Associate Program Director, Breast Surgical Oncology Fellowship
  • Assistant Professor of Clinical Surgery
  • Dr. Rothman is a Penn Medicine physician.
Call 215-615-2992 Request Appointment

Meet Dr. Rothman

Dr. Rothman received her undergraduate degree from Cornell University, and her Master of Science in Public Health from Harvard University. While at Harvard, she studied the impact of racism and poverty on cancer prevention in low-income populations, as well as the intertwining of provider- and systems-level interventions to measure their effects on cancer screening and early detection.

She received her medical degree from the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, where she stayed to complete her general surgery residency. She subsequently completed her fellowship in breast surgical oncology at the University of California, San Francisco, where she was trained in some of the most innovative operative techniques, including nipple-sparing mastectomies, tumor and sentinel node localization, intraoperative radiation therapy, and oncoplastic surgery.

Dr. Rothman’s research has focused on the active surveillance of ductal carcinoma in situ (DCIS), intraoperative radiation therapy, as well as the application of precision medicine to the prevention and treatment of breast cancer. She is additionally interested in the racial and ethnic disparities in breast cancer surgery delay and the subsequent effects on stage migration and upstaging of disease.

Back To Top